Deutsche Lufthansa (OTCMKTS: DLAKY) share rating downgraded by Goldman Sachs group
Deutsche Lufthansa (OTCMKTS: DLAKY) was downgraded by equity researchers at Goldman Sachs from a “neutral” rating to a “sell” rating in a note issued to investors on Monday, Fly reports.
Several other equity research analysts also recently commented on the stock. Kepler Capital Markets downgraded Deutsche Lufthansa’s stock rating from a “buy” rating to a “keep” rating in a research report published on Friday, April 23. Societe Generale reissued a “sell” note on Deutsche Lufthansa shares in a research note on Thursday (February 18th). Credit Suisse Group reaffirmed an “underperformance” rating on Deutsche Lufthansa shares in a report released Tuesday, May 4. Berenberg Bank reiterated a “sell” note on Deutsche Lufthansa shares in a report released on Monday (March 8). To finish, Zacks investment research changed Deutsche Lufthansa from a “buy” note to a “keep” note in a Tuesday May 11 research note. Eight analysts rated the stock with a sell rating and two gave the stock a conservation rating. The stock currently has a consensus rating of “Sell” and an average price target of $ 16.00.
Actions of OTCMKTS: DLAKY traded up $ 0.13 in Monday’s session, reaching $ 13.28. 48,735 shares of the stock were traded, for an average volume of 45,312. Deutsche Lufthansa has a one-year low at $ 8.11 and a one-year high at $ 15.56. The stock has a fifty-day moving average price of $ 13.14. The company has a leverage ratio of 8.83, a quick ratio of 0.64, and a current ratio of 0.68. The stock has a market cap of $ 7.94 billion, a price-to-earnings ratio of -0.87 and a beta of 1.39.
Deutsche Lufthansa (OTCMKTS: DLAKY) last announced its quarterly results on Thursday, March 4. The transportation company reported ($ 2.53) EPS for the quarter. Deutsche Lufthansa had a negative net margin of 49.68% and a negative return on equity of 120.84%. The company posted revenue of $ 3.09 billion for the quarter. Stock analysts expect Deutsche Lufthansa to post earnings per share of -4.15 for the current fiscal year.
An institutional investor recently increased its position in Deutsche Lufthansa stock. Captrust Financial Advisors increased its stake in shares of Deutsche Lufthansa AG (OTCMKTS: DLAKY) by 665.5% in the fourth quarter, according to its latest Form 13F filed with the Securities and Exchange Commission. The company held 2,220 shares of the transport company after acquiring an additional 1,930 shares during the quarter. Captrust Financial Advisors’ holdings in Deutsche Lufthansa were worth $ 29,000 at the time of its last filing with the SEC. Institutional investors hold 0.08% of the company’s shares.
Deutsche Lufthansa Company Profile
Deutsche Lufthansa AG operates as an airline in Germany and internationally. The company’s Network Airlines segment provides passenger services through a network of routes to 273 destinations in 86 countries. Its Eurowings segment provides passenger services through a network of routes to more than 210 destinations in 60 countries.
Read more: What is the Shanghai Stock Exchange Composite Index?
This instant news alert was powered by storytelling technology and MarketBeat financial data to provide readers with the fastest, most accurate reports. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured article: What does a market performance score mean?
7 health actions serving innovation in 2021
We all knew that traditional health services were disrupted in 2020. The patient-doctor relationship has gone virtual. During the first months of the pandemic, many people in need of elective surgeries simply did not have this option available to them. And even local pharmacies have taken on a new role in e-commerce as curbside pickup or home delivery of prescription drugs has become the norm.
It’s no surprise that healthcare stocks took a rough ride last year. Overall, the sector was down 11%, well below the S&P 500 which climbed more than 15%.
However, the market is always looking to the future with a particular eye on innovation. The healthcare sector has many companies that are developing innovative approaches in areas such as gene editing. And other companies are in the advanced testing phase for drugs that can deliver groundbreaking results for conditions that continue to plague our world.
This is the object of this presentation. We have identified 7 healthcare actions that offer innovative ideas that will help achieve better patient outcomes. And in some cases, it will completely revolutionize medicine. These are also the stocks that analysts watch.
Consult the “7 healthcare stocks for innovation in 2021”.